Analysis: Stocks

Adyen slows down

The Dutch payments specialist has published half-year results that are up but slightly below expectations. The outlook has been revised downward. The stock is down nearly 20% this morning in...

Reddit ready to surf the wave

Does the rise of artificial intelligence really justify the exuberant stockmarket valuation of the online community platform?

Automotive: Porsche SE sees its salvation in defense

At MarketScreener, people who think a lot about investments had been flagging for some time the hypothesis that the ailing automotive industry could not remain deaf to the billions promised to the...

SS&C Technologies: growth prospects and brand unification

SS&C Technologies has reported strong Q2 25 results, with revenue growth driven by its core financial services and healthcare software businesses. The company has consistently outperformed analysts'...

Federal Signal scaling up through acquisitions

Federal Signal reported record sales growth and earnings improvement in Q2 25, delivering double-digit y/y sales and earnings growth driven by robust customer demand and higher production across...

CoreWeave's Cloud Conundrum: Growth at Full Throttle, Losses in Tow

CoreWeave, one of the most prominent new names in AI infrastructure, posted second-quarter revenue of $1.21 billion, up 207% from a year earlier and comfortably ahead of Wall Street's $1.08bn...

Valneva: the return of biotech euphoria?

The Franco-Austrian laboratory, which generated a lot of excitement during the Covid-19 pandemic with its attempt to develop a vaccine, has been staging a strong rebound since the beginning of last...

Caught up by the economic situation, Dow halves its dividend

These are tough times for the chemical industry, whose difficulties reflect the slowdown in the economy, particularly since the introduction of tariffs.

Servicenow continues to shine with strategic integration

Servicenow has delivered a strong Q2 25 performance, showcasing robust growth across its business segments. Results were driven by a significant increase in net sales, primarily from high-margin...

Mastercard expands horizons with stablecoins

Mastercard delivered robust Q2 25 results, with solid growth across all business segments, supported by volume expansion and increased cross-border activity. Profitability was further boosted by...

UnitedHealth: Strategic shift in response to the crisis

There are moments in the life of a company when the tide turns, sometimes abruptly. For UnitedHealth Group, the largest health insurer in the US, 2025 will be remembered as a year of turmoil. Against...

Monster Beverage: energy that reassures

The US energy drink specialist surprised with better-than-expected quarterly results and summer sales momentum that supports analysts' optimistic forecasts.

Bechtle is back on track

Bechtle is a German group specializing in the distribution of IT hardware, software, and IT services for businesses and public administrations. It operates through a large network of local agencies...

Another day of carnage for Orsted

Orsted shares slumped 23% after announcing a huge capital increase representing nearly half of its market capitalization. Analysts were surprised by the size of the operation and not reassured by the...

AirTAC sees opportunities amidst industry growth

AirTAC International Group has delivered a strong top-line performance in Q2 25, reflecting strong demand across markets. Revenue performance underscored operational momentum, and the company has...

Hess Midstream unlocks growth from Chevron merger

Hess has posted strong operational and financial results for Q2 25, driven by production strength and reliable infrastructure operations. Efficient system utilization and disciplined cost management...

AtriCure, Inc. : Positioned for Growth in Surgical Afib Solutions

AtriCure specializes in cardiac surgical solutions, focusing on devices and therapies for atrial fibrillation , left atrial appendage management, and post-operative pain control. It has developed...

Palantir in five figures

The tech-savvy's favorite stock continues to break records on the stockmarket this week. Here are five figures that help to better understand the phenomenon....

Sandoz has significant clinical visibility

After a convincing first half, the Swiss generic and biosimilar drugs company is continuing its strong performance of recent weeks, with the stock rising 12% on Thursday.